One‐Stop Plasmonic Nanocube‐Excited SERS Immunoassay Platform of Multiple Cardiac Biomarkers for Rapid Screening and Progressive Tracing of Acute Myocardial Infarction
Small · 2024-02 · 20 (8)
DOI: 10.1002/smll.202304999 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 11.10.2023. Verfasst von Hyerin Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Medicine, Kyung Hee University, 02447, Seoul, South Korea. Hauptthemen laut MEDLINE: Myocardial Infarction. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Basic Science Research Program, National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
Rapid and precise acute myocardial infarction (AMI) diagnosis is essential for preventing patient death. In addition, the complementary roles of creatine kinase muscle brain (CK‐MB) and cardiac troponin I (cTnI) cardiac biomarkers in the early and late stages of AMI demand their simultaneous detection, which is difficult to implement using conventional fluorescence and electrochemical technologies. Here, a nanotechnology‐based one‐stop immuno‐surface‐enhanced Raman scattering (SERS) detection platform is reported for multiple cardiac indicators for the rapid screening and progressive tracing of AMI events. Optimal SERS is achieved using optical property‐based, excitation wavelength‐optimized, and high‐yield anisotropic plasmonic gold nanocubes. Optimal immunoassay reaction efficiencies are achieved by increasing immobilized antibodies. Multiple simultaneous detection strategies are implemented by incorporating two different Raman reports with narrow wavenumbers corresponding to two indicators and by establishing a computational SERS mapping process to accurately detect their concentrations, irrespective of multiple enzymes in the human serum. The SERS platform precisely estimated AMI onset and progressive timing in human serum and made rapid AMI identification feasible using a portable Raman spectrometer. This integrated platform is hypothesized to significantly contribute to emergency medicine and forensic science by providing timely treatment and observation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, College of Medicine, Kyung Hee University, 02447, Seoul, South Korea.
- Division of Cardiology, Department of Internal Medicine, Kyung Hee University, 02447, Seoul, South Korea.
- Department of Nano-Bio Convergence, Korea Institute of Materials Science (KIMS), 51508, Gyeongnam, South Korea.
- School of Convergence Science and Technology, Medical Science and Engineering, POSTECH, Kyungbuk, 37673, South Korea.
ORCID-Profile: Wansun Kim, Samjin Choi
Förderung
- Basic Science Research Program
- National Research Foundation of Korea
- Ministry of Education
- Fundamental Research Program
- Korea Institute of Materials Science
Zitieren
APA
Lee, H., Kim, W., Song, M. Y., Kim, D. H., Jung, H. S., Kim, W., & Choi, S. (2024). One‐Stop Plasmonic Nanocube‐Excited SERS Immunoassay Platform of Multiple Cardiac Biomarkers for Rapid Screening and Progressive Tracing of Acute Myocardial Infarction. Small, 20(8). https://doi.org/10.1002/smll.202304999
Vancouver
Lee H, Kim W, Song MY, Kim DH, Jung HS, Kim W, et al. One‐Stop Plasmonic Nanocube‐Excited SERS Immunoassay Platform of Multiple Cardiac Biomarkers for Rapid Screening and Progressive Tracing of Acute Myocardial Infarction. Small. 2024;20(8). doi:10.1002/smll.202304999
BibTeX
@article{Lee2024,
author = {Lee, Hyerin and Kim, Wansun and Song, Min-Young and Kim, Dong-Ho and Jung, Ho Sang and Kim, Weon and Choi, Samjin},
title = {One‐Stop Plasmonic Nanocube‐Excited SERS Immunoassay Platform of Multiple Cardiac Biomarkers for Rapid Screening and Progressive Tracing of Acute Myocardial Infarction},
journal = {Small},
year = {2024},
volume = {20},
number = {8},
doi = {10.1002/smll.202304999}
}
EUVIMED